Spirent acquires Hekimian Laboratories in combined cash and paper deal worth £1.11bn. Spirent advised by Linklaters (Shane Griffin) and Debevoise & Plimpton (Robert Quaintance), financial advisers Schroder Salomon Smith Barney and Rothschild, brokers Cazenove & Co and accountants Ernst & Young. Hekimian represented by Skadden Arps Slate Meagher & Flom (Alan Myers) and financial adviser Goldman Sachs.